Search
for
Sort by
Research 151–180 of 1000+
- Common Causes of Hair Loss and Their Treatment Options
- Acquired Alopecias in Mexican Adults: A Clinical and Epidemiological Study of 1,888 Patients
- Efficacy and Safety of Mesotherapy With 0.5% Minoxidil Versus Topical 2% Minoxidil for Female Androgenetic Alopecia: A Randomized Controlled Trial
- Therapeutic experience with oral finasteride for androgenetic alopecia in female-to-male transgender patients
- Women With Polycystic Ovary Syndrome: A Review of Susceptibility to Type 2 Diabetes
- Modern and Promising Strategies for Treatment of Alopecia in the United States: Clinical and Pharmacological, Marketing, Regulatory, SWOT Analysis
- Efficacy and safety of superficial cryotherapy for alopecia areata: A retrospective, comprehensive review of 353 cases over 22 years
- Metabolic syndrome in androgenic alopecia
- Mandibulofacial dysostosis with alopecia results from ETAR gain-of-function mutations via allosteric effects on ligand binding
- Host-Directed FDA-Approved Drugs with Antiviral Activity against SARS-CoV-2 Identified by Hierarchical In Silico/In Vitro Screening Methods
- Effects of age and sex on the comorbidities of alopecia areata: A cross‐sectional hospital‐based study
- Early-onset Male Androgenetic Alopecia and Metabolic Syndrome: Are They Associated?
- Treatment of periorbital aging with negative pressure fractional microneedle radiofrequency: A self‐controlled clinical trial
- Comorbidities in Androgenetic Alopecia: A Comprehensive Review
- Early androgenetic alopecia as a possible indicator of diabetes mellitus and its link to cardiovascular risks: a cross-sectional study
- Androgenic alopecia, premature graying, and hair thinning as independent predictors of coronary artery disease in young Asian males
- Complete Pseudo-Anodontia in an Adult Woman with Pseudo-Hypoparathyroidism Type 1a: A New Additional Nonclassical Feature?
- Caizhixuan hair tonic regulates both apoptosis and the PI3K/Akt pathway to treat androgenetic alopecia
- Shock: A possible presenting manifestation of autoimmune polyendocrine syndrome type II
- Risks for metabolic syndrome and cardiovascular diseases in both male and female patients with androgenetic alopecia
- The prevalence of metabolic syndrome in male patients of early onset androgenic alopecia compared to age matched controls
- Caffeic acid N-[3,5-bis(trifluoromethyl)phenyl] amide as a non-steroidal inhibitor for steroid 5α-reductase type 1 using a human keratinocyte cell-based assay and molecular dynamics
- Comparison of High-Dose Corticosteroid Pulse Therapy and Combination Therapy Using Oral Cyclosporine with Low-Dose Corticosteroid in Severe Alopecia Areata
- A finasteride patch for the treatment of androgenetic alopecia: A study of promoting permeability strategy using synthetic novel O-acylmenthols combined with ion-pair
- Natural Product-Inspired Bis(trifluoromethyl) Phenyl Hydroxycinnamate Derivatives as Promising Nonsteroidal Inhibitors of Human Steroid 5α-Reductase Type-1: Synthesis, <i>In Vitro</i>, and <i>In Silico</i> Studies
- Involvement of mechanical stress in androgenetic alopecia
- Hypoparathyroidism as the single major component for decades of autoimmune polyglandular syndrome type 1
- Bioprospecting of Potential Inhibitors of 5alpha Reductase 2 Inhibitors from Relevant Ethno-pharmacological Plants via In Silico Techniques
- Thermodynamic Modeling of the Gas-Antisolvent (GAS) Process for Precipitation of Finasteride
- Acquired Acrodermatitis Enteropathica in a 28-Year-Old Male with Type 1 Diabetes